|
Volumn 29, Issue 1, 2015, Pages 7-18
|
Development of two salmonella-based oral vaccines against human respiratory syncytial virus
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
EPITOPE;
G GLYCOPROTEIN, RESPIRATORY SYNCYTIAL VIRUS;
RECOMBINANT VACCINE;
RESPIRATORY SYNCYTIAL VIRUS VACCINE;
VIRUS FUSION PROTEIN;
ANIMAL;
BAGG ALBINO MOUSE;
CELL PROLIFERATION;
DRUG EFFECTS;
GENETICS;
HUMAN RESPIRATORY SYNCYTIAL VIRUS;
HUMORAL IMMUNITY;
IMMUNOLOGY;
LUNG;
LYMPHOCYTE;
METABOLISM;
PATHOLOGY;
PLASMID;
SALMONELLA ENTERICA SEROVAR TYPHI;
TH1 CELL;
TH2 CELL;
VIROLOGY;
ANIMALS;
CELL PROLIFERATION;
EPITOPES;
IMMUNITY, HUMORAL;
LUNG;
LYMPHOCYTES;
MICE, INBRED BALB C;
PLASMIDS;
RESPIRATORY SYNCYTIAL VIRUS VACCINES;
RESPIRATORY SYNCYTIAL VIRUS, HUMAN;
SALMONELLA TYPHI;
TH1 CELLS;
TH2 CELLS;
VACCINES, SYNTHETIC;
VIRAL FUSION PROTEINS;
|
EID: 84932097869
PISSN: 0393974X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|